Yes, Prevnar 20 and Td Can Be Given at the Same Time
Prevnar 20 (PCV20) and Td vaccine can be safely administered concomitantly during the same visit, using separate syringes at different anatomic sites. This practice is supported by established vaccination principles and clinical evidence.
Key Administration Guidelines
The general principle for simultaneous vaccination is well-established: if two or more vaccines are indicated, they should be administered during the same visit 1, 2. Each vaccine must be given using a separate syringe at a different anatomic site, with experts recommending no more than two injections per muscle, separated by at least one inch 1, 2.
Practical Administration Details
- Prevnar 20: 0.5 mL administered intramuscularly, preferably into the deltoid muscle 3
- Td: 0.5 mL administered intramuscularly, preferably into the deltoid muscle 2
- Site separation: Use different anatomic sites (e.g., one in each deltoid)
- Timing advantage: Administering all indicated vaccines during a single visit increases the likelihood that patients will receive each vaccination on schedule 1, 2
Supporting Evidence
General Vaccine Coadministration Principles
The ACIP guidelines explicitly state that inactivated vaccines can be administered at any time before or after a different inactivated or live vaccine (nonsimultaneous vaccination), unless a contraindication exists 1. Both Prevnar 20 and Td are inactivated vaccines, making them compatible for simultaneous administration.
Specific Evidence for Pneumococcal Vaccines with Td
While the provided evidence primarily addresses Tdap (tetanus-diphtheria-pertussis) rather than Td specifically, the principles apply equally:
- Clinical trials have demonstrated that PCV13 can be safely coadministered with tetanus-diphtheria vaccines 4
- A study of 448 adults aged ≥50 years showed that concomitant Td and PCV13 administration induced sufficient immunity without significant interference and demonstrated good safety profiles 4
- PCV20 has been studied with concomitant administration of other vaccines, including COVID-19 boosters and influenza vaccines, with similar safety profiles to separate administration 5
Important Caveats
Potential Immune Interference
There is one important consideration regarding timing: Some research suggests that prior administration of tetanus/diphtheria-containing vaccines 3-4 weeks before pneumococcal conjugate vaccines may reduce antibody response to certain pneumococcal serotypes 6, 7. Specifically:
- When Tdap was given 3-4 weeks before PCV13, significantly lower geometric mean titers were observed for 6-7 pneumococcal serotypes 6, 7
- However, concomitant administration (same day) did not show this suppressive effect 4, 7
Clinical implication: If both vaccines are needed, simultaneous administration on the same day is preferable to sequential administration with a 3-4 week interval. This avoids potential immune interference while ensuring timely protection.
Safety Profile
The safety of concomitant administration is well-established:
- No serious adverse events related to concomitant administration have been reported 4
- Local reactions and systemic events are generally mild to moderate and similar whether vaccines are given together or separately 3
- Syncope can occur after vaccination and may be more common in adolescents and young adults; consider a 15-20 minute observation period 1
Clinical Bottom Line
Administer Prevnar 20 and Td concomitantly during the same visit when both are indicated. Use separate syringes, different anatomic sites (preferably one in each deltoid), and separate injection sites by at least one inch if using the same muscle. This approach maximizes vaccination completion rates, avoids potential immune interference from sequential administration, and maintains excellent safety profiles.